Risk of pancreatic cancer after eradication treatment of Helicobacter pylori

This publication has 14 references indexed in Scilit:

• Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori
  Gastroenterology, 2025
• Associations between colonization with Helicobacter pylori and risk of gastrointestinal tract cancers: An umbrella review of meta‐analyses
  European Journal of Clinical Investigation, 2025
• Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study
  Gastroenterology, 2024
• European Registry onHelicobacter pylorimanagement (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
  Gut, 2020
• The association of Helicobacter pylori with pancreatic cancer
  GastroHep, 2020
• Helicobacter pylorieradication therapy to prevent gastric cancer: systematic review and meta-analysis
  Gut, 2020
• Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer
  Gut, 2019
• Nordic Cancer Registries – an overview of their procedures and data comparability
  Acta Oncologica, 2017
• Review article: the global emergence ofHelicobacter pyloriantibiotic resistance
  Alimentary Pharmacology & Therapeutics, 2015
• Incidence and mortality of pancreatic cancer in the Nordic countries 1971–2000
  Acta Oncologica, 2007